- Zacks
Pharma Stock Roundup: AZN, SNY, ABBV Q2 Earnings, PFE & MRK's Positive Pipeline News
AstraZeneca (AZN), Sanofi (SNY) and AbbVie (ABBV) announce second-quarter results. Merck (MRK) and Pfizer's (PFE) phase III studies achieve primary goals.
- Investor's Business Daily
AstraZeneca Says It Has A 'Powerful' — And Differentiated — Approach To Obesity Treatment
AstraZeneca stock skidded Thursday despite strong quarterly sales as an FDA panel met to discuss its lung cancer treatment.
- Motley Fool
Sanofi (SNY) Q2 2024 Earnings Call Transcript
SNY earnings call for the period ending June 30, 2024.
